Daily Management and Treatment Options
At a Glance
The primary treatment for Epidermolytic palmoplantar keratoderma (EPPK) is a daily routine of soaking, gently exfoliating, and applying keratolytics and heavy emollients. While there is no cure, this consistent care prevents painful skin cracks and improves daily mobility.
Managing Epidermolytic palmoplantar keratoderma (EPPK) is a lifelong commitment focused on comfort and mobility. While there is currently no cure, a consistent daily routine can significantly reduce pain, prevent infections, and improve the function of your hands and feet [1][2].
Standard Symptom Management
The primary goal of treatment is to safely thin the thickened skin and keep it flexible to prevent painful cracks, known as fissures [1][3].
- Keratolytics: These are agents that help break down and “dissolve” excess keratin. Common ingredients include urea (which also hydrates) and salicylic acid [4][5].
- Emollients: Heavy, oil-based moisturizers (like petroleum jelly) should be applied frequently to trap moisture in the skin and maintain flexibility [1].
- Topical Steroids: These may be used for short periods to reduce inflammation and redness (the “halo” effect) around the lesions [6].
- Topical Antimicrobials: Products like selenium sulfide or gentamicin ointment may be recommended to manage odor (bromhidrosis) or reduce the bacterial load in the skin folds [7].
Advanced and Systemic Treatments
For cases where topical creams are not enough to manage the thickening, a dermatologist may suggest more intensive options.
- Low-Dose Oral Retinoids (Acitretin): These oral medications can be very effective at slowing down the overproduction of skin cells [8]. Safety Warning: In epidermolytic conditions like EPPK, retinoids must be dosed extremely carefully. Thinning the skin too much can “unmask” the underlying structural fragility of the cells, causing severe blistering, raw skin, and intense pain [8]. These medications require strict monitoring and regular blood tests [8].
- Highly Experimental Surgery: In extraordinarily rare and debilitating cases where all other options have failed, a specialized reconstructive surgery involving the removal of the thickened skin and the use of a collagen bilayer matrix (a structural skin substitute) and grafting has been attempted [9]. This is an absolute last resort, highly experimental procedure. It carries risks of scarring and recurrence, and the vast majority of patients will never need to consider it.
Daily Care Checklist
Consistency is the most important factor in managing EPPK. Many families find a daily routine helpful:
- Soak: Soak hands or feet in warm water for 15–20 minutes to soften the keratin.
- Exfoliate: Gently use a pumice stone or specialized file to remove softened skin. Never perform “bathroom surgery.” You should never use razor blades or scissors to cut or deeply debride your own skin, as this drastically increases the risk of serious infection. Deep paring should only be performed by a professional podiatrist or dermatologist.
- Medicate: Apply prescribed keratolytics (like urea cream).
- Seal: Apply a thick layer of emollient (like Vaseline) over the entire area.
- Protect: Wear cotton gloves or socks, especially at night, to help the treatments soak in and protect the skin.
The Future: Gene and Molecular Therapy
Research is moving toward treating the genetic cause of EPPK rather than just the symptoms.
- CRISPR/Cas9: In laboratory settings, scientists have successfully used CRISPR to “edit” or reduce the expression of mutant KRT9 proteins [10].
- siRNA (Small Interfering RNA): Researchers are designing molecules that can “silence” the faulty gene, allowing only the healthy gene to produce keratin [11][12].
It is important to manage expectations regarding timelines: these treatments are currently in the preclinical stage, meaning they are being studied in labs and animal models [1][13]. It will likely be many years before they are available to patients as a potential “molecular cure.”
| Management Strategy | Main Goal |
|---|---|
| Professional Paring | Reducing physical thickness safely (must be done by a podiatrist/doctor). |
| Fissure Care | Using “liquid bandage” or specialized tapes to seal and heal minor cracks. |
| Footwear Choice | Selecting wide, cushioned shoes or orthotics to reduce friction and pressure. |
| Pain Management | Using topical lidocaine or oral anti-inflammatories for flare-ups. |
Common questions in this guide
What are the best topical creams for treating EPPK?
Are there oral medications available for Epidermolytic palmoplantar keratoderma?
Is it safe to cut or file the thick skin on my hands and feet?
How can I prevent the skin on my feet from cracking and bleeding?
Will there ever be a cure for EPPK?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which concentration of urea or salicylic acid is safest for my child's age?
- 2.If we consider low-dose acitretin, what kind of long-term monitoring (like blood tests) will be required?
- 3.Can you recommend a specific type of footwear or orthotics to help reduce pressure and pain on the soles of the feet?
- 4.How can we tell the difference between a normal skin crack and a crack that has become infected?
- 5.Are there any clinical trials currently recruiting for KRT9 or KRT1 gene therapies?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
Treatment of hereditary palmoplantar keratoderma: a review by analysis of the literature.
Bodemer C, Steijlen P, Mazereeuw-Hautier J, O'Toole EA
The British journal of dermatology 2021; (184(3)):393-400 doi:10.1111/bjd.19144.
PMID: 32307694 - 2
Keratin 9 L164P mutation in a Chinese pedigree with epidermolytic palmoplantar keratoderma, cytokeratin analysis, and literature review.
Liu X, Qiu C, He R, et al.
Molecular genetics & genomic medicine 2019; (7(11)):e977 doi:10.1002/mgg3.977.
PMID: 31525823 - 3
Two patients with Papillon-Lefèvre syndrome without periodontal involvement of the permanent dentition.
Umlauft J, Schnabl D, Blunder S, et al.
The Journal of dermatology 2021; (48(4)):537-541 doi:10.1111/1346-8138.15720.
PMID: 33580910 - 4
Pain mechanisms in hereditary palmoplantar keratodermas.
Weinberg RL, Coulombe PA, Polydefkis M, Caterina MJ
The British journal of dermatology 2020; (182(3)):543-551 doi:10.1111/bjd.17880.
PMID: 30883689 - 5
Topical Selenium Sulfide for the Treatment of Hyperkeratosis.
Cohen PR, Anderson CA
Dermatology and therapy 2018; (8(4)):639-646 doi:10.1007/s13555-018-0259-9.
PMID: 30203232 - 6
Genetic Analysis of KRT9 Gene Revealed Previously Known Mutations and Genotype-Phenotype Correlations in Epidermolytic Palmoplantar Keratoderma.
Li Y, Tang L, Han Y, et al.
Frontiers in genetics 2018; (9()):645 doi:10.3389/fgene.2018.00645.
PMID: 30666268 - 7
Effect of Gentamicin Ointment in Patients with Nagashima-type Palmoplantar Keratosis: A Double-blind Vehicle-controlled Study.
Li Y, Yu X, Pan C, et al.
Acta dermato-venereologica 2021; (101(2)):adv00392 doi:10.2340/00015555-3760.
PMID: 33554268 - 8
Pachyonychia Congenita (K16) with Unusual Features and Good Response to Acitretin.
Almutawa F, Thusaringam T, Watters K, et al.
Case reports in dermatology 2015; (7(2)):220-6 doi:10.1159/000438920.
PMID: 26464567 - 9
Collagen Matrix and Staged Skin Grafting for Plantar Reconstruction: Lessons Learned in Treatment of Palmoplantar Keratoderma.
Choi J, Applebaum MA, Feldmann ME
Eplasty 2024; (24()):e67.
PMID: 40463924 - 10
CRISPR/Cas9-Mediated Treatment Ameliorates the Phenotype of the Epidermolytic Palmoplantar Keratoderma-like Mouse.
Luan XR, Chen XL, Tang YX, et al.
Molecular therapy. Nucleic acids 2018; (12()):220-228 doi:10.1016/j.omtn.2018.05.005.
PMID: 30195761 - 11
Six generations of epidermolytic palmoplantar keratoderma, associated with a KRT9 R163W mutation.
Wang P, Kang XJ, Tang XH, et al.
Cancer genetics 2016; (209(11)):515-524 doi:10.1016/j.cancergen.2016.10.002.
PMID: 27864007 - 12
Identification of a Novel Keratin 9 Missense Mutation in a Chinese Family with Epidermolytic Palmoplantar Keratoderma.
Xiao H, Guo Y, Yi J, et al.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2018; (46(5)):1919-1929 doi:10.1159/000489381.
PMID: 29719290 - 13
A Small Indel Mutant Mouse Model of Epidermolytic Palmoplantar Keratoderma and Its Application to Mutant-specific shRNA Therapy.
Lyu YS, Shi PL, Chen XL, et al.
Molecular therapy. Nucleic acids 2016; (5()):e299 doi:10.1038/mtna.2016.17.
PMID: 27003758
This guide provides educational information on daily care routines and treatments for EPPK. Always consult your dermatologist or podiatrist before starting new treatments or altering your skin care regimen.
Get notified when new evidence is published on Epidermolytic palmoplantar keratoderma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.